Biomind Labs Inc. (BMNDF)
USD 0.31
(0.0%)
USD 0.31
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -779.97 Thousand | -2.15 Million | -2.12 Million | -150.12 Thousand | -608.21 Thousand | -810.02 Thousand |
| Net Income | -1.21 Million | -2.98 Million | -4.33 Million | -190.04 Thousand | -363.59 Thousand | -1.13 Million |
| Depreciation & Amortization | 15.42 Thousand | 44.24 Thousand | 28.32 Thousand | - | - | 15 Thousand |
| Deferred income taxes | - | 49.31 Thousand | 64.46 Thousand | - | - | - |
| Stock-based compensation | 7503.00 | 553.61 Thousand | 1.38 Million | - | - | - |
| Change in working capital | 233.61 Thousand | 186.07 Thousand | -104.21 Thousand | 39.91 Thousand | -244.62 Thousand | 192.85 Thousand |
| Other non-cash items | 216.15 Thousand | 1361.00 | 840.22 Thousand | -39.91 Thousand | 244.62 Thousand | -45.94 Thousand |
| Investing Cash Flow | - | - | -44.34 Thousand | - | - | 12.66 Million |
| Investments in PPE | 0.26 | - | -44.59 Thousand | - | - | - |
| Acquisitions | - | - | 250.00 | - | - | 11.4 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | 1.26 Million |
| Other Investing Activities | - | - | - | - | - | 1.00 |
| Financing Cash Flow | 776.43 Thousand | -38.52 Thousand | 4.47 Million | -108.3 Thousand | -741.08 Thousand | -14.44 Million |
| Debt repayment | -784.83 Thousand | -38.52 Thousand | -30.49 Thousand | - | - | - |
| Dividends payments | - | - | - | -108.3 Thousand | -741.08 Thousand | -12.78 Million |
| Common Stock Repurchased | - | - | - | - | - | -30.75 Thousand |
| Common Stock Issuance | - | - | 4.5 Million | - | - | - |
| Other Financing Activities | -8400.28 | - | 4501.36 | 12 Thousand | - | -1.63 Million |
| Accounts receivables | - | - | - | 31.16 Thousand | -23.97 Thousand | 121.01 Thousand |
| Accounts payables | - | - | - | 8750.39 | -220.65 Thousand | 71.84 Thousand |
| Inventory | - | - | - | 177.51 | - | - |
| Other working capital | 233.61 Thousand | 186.07 Thousand | -104.21 Thousand | -177.90 | - | - |
| Cash at beginning of period | 26.14 Thousand | 2.27 Million | 82.03 Thousand | 334.49 Thousand | 1.56 Million | 4.63 Million |
| Cash at end of period | 24.14 Thousand | 26.15 Thousand | 2.27 Million | 82.03 Thousand | 334.49 Thousand | 1.56 Million |
| Capital Expenditure | 0.26 | - | -44.59 Thousand | - | - | - |
| Effect of forex changes on cash | 1584.00 | -58.09 Thousand | -30.23 Thousand | - | - | 0.21 |
| Net cash flow / Change in cash | -2004.00 | -2.24 Million | 2.19 Million | -252.45 Thousand | -1.22 Million | -3.07 Million |
| Free Cash Flow | -779.97 Thousand | -2.15 Million | -2.16 Million | -150.12 Thousand | -608.21 Thousand | -810.02 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -212.01 Thousand | -185.32 Thousand | -279.57 Thousand | -1.21 Million | -125.61 Thousand | -361.11 Thousand |
| Depreciation & Amortization | 2229.54 | 2220.04 | -1.00 | 15.42 Thousand | 2230.00 | 8150.00 |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | 7503.00 | - | - |
| Change in working capital | 80.51 Thousand | -6966.74 | -92.11 Thousand | 233.61 Thousand | -9855.00 | 187.41 Thousand |
| Other non-cash items | 107.91 Thousand | 79.58 Thousand | 156.6 Thousand | 216.15 Thousand | -3021.00 | 1642.00 |
| Investing Cash Flow | - | - | - | - | - | - |
| Investments in PPE | -3.07 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 77.65 Thousand | 88.86 Thousand | 110.12 Thousand | 776.43 Thousand | 228.66 Thousand | 157.66 Thousand |
| Debt repayment | -77.65 Thousand | -88.86 Thousand | -784.83 Thousand | -784.83 Thousand | -664.92 Thousand | -1238.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 77.57 | - | -675.72 Thousand | - | 228.66 Thousand | 158.9 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 80.51 Thousand | -6966.74 | -92.11 Thousand | 233.61 Thousand | -9855.00 | 187.41 Thousand |
| Cash at beginning of period | 46.48 Thousand | 24.14 Thousand | 128.39 Thousand | 26.14 Thousand | 60.93 Thousand | 14.13 Thousand |
| Cash at end of period | 33.22 Thousand | 46.48 Thousand | 24.14 Thousand | 24.14 Thousand | 129.01 Thousand | 60.93 Thousand |
| Capital Expenditure | -3.07 | - | - | - | - | - |
| Effect of forex changes on cash | -21.17 Thousand | 3903.00 | -1470.00 | 1584.00 | -24.32 Thousand | 53.04 Thousand |
| Net cash flow / Change in cash | -13.26 Thousand | 22.34 Thousand | -104.25 Thousand | -2004.00 | 68.07 Thousand | 46.79 Thousand |
| Free Cash Flow | -25.81 Thousand | -114.92 Thousand | -215.08 Thousand | -779.97 Thousand | -136.26 Thousand | -163.91 Thousand |
CLOEF
CPI
2636
ZKH
ACENY
TAGM-B